101
Participants
Start Date
November 30, 2012
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
FTC/TDF (Truvada®)
There are no interventions for this study except that subjects will be administered FTC/TDF (Truvada®) will be administered as part of ATN 110 and ATN 113.
Children's Hopsital of Philadelphia, Philadelphia
Johns Hopkins University, Baltimore
University of Miami, Miami
University of South Florida, Tampa
St. Jude Childrens Research Hospital, Memphis
Wayne State University, Detroit
Stroger Hospital and the CORE Center, Chicago
Tulane University, New Orleans
Baylor College of Medicine, Houston
Children's Hospital of Denver, Aurora
Children's Hopsital of Los Angeles, Los Angeles
Fenway Institute, Boston
National Institute on Drug Abuse (NIDA)
NIH
National Institute of Mental Health (NIMH)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of North Carolina, Chapel Hill
OTHER